Type three secretion system-mediated escape of Burkholderia pseudomallei into the host cytosol is critical for the activation of NFκB

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Teh, Boon Eng ^a   French, Christopher Todd ^b   Chen, Yahua ^a   Chen, Isabelle Gek Joo ^a   Wu, Ting Hsiang ^b   Sagullo, Enrico ^b   Chiou, Pei Yu ^b,c   Teitell, Michael A ^b,c,d,e,f   Miller, Jeff F ^b,c,f   Gan, Yunn Hwen ^a,g  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Department of Microbiology Immunology and Molecular Genetics ^*  (United States)

^c CALIFORNIA NANOSYSTEMS INSTITUTE   (United States)

^d Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR;

ARTICLE; BACTERIAL COUNT; BACTERIUM MUTANT; BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA THAILANDENSIS; CELL DEATH; CONTROLLED STUDY; CYTOSOL; ENDOSOME; EUKARYOTIC CELL; GENE CLUSTER; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPRECIPITATION; MELIOIDOSIS; NONHUMAN; PROTEIN PHOSPHORYLATION; TYPE III SECRETION SYSTEM;

BACTERIA (MICROORGANISMS); BURKHOLDERIA PSEUDOMALLEI; NEGIBACTERIA;

EID: 84901435123     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-14-115     Document Type: Article

References (44)

1. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Galyov EE, Brett PJ, DeShazer D, Annu Rev Microbiol 2010 64 495 517 10.1146/annurev.micro.112408.134030 20528691
2. Intracellular survival of Burkholderia pseudomallei. Jones AL, Beveridge TJ, Woods DE, Infect Immun 1996 64 3 782 790 8641782 (Pubitemid 26065549)
3. Melioidosis. Wiersinga WJ, Currie BJ, Peacock SJ, N Engl J Med 2012 367 11 1035 1044 10.1056/NEJMra1204699 22970946
4. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ, Nat Rev Microbiol 2006 4 4 272 282 10.1038/nrmicro1385 16541135
5. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis. Stevens MP, Haque A, Atkins T, Hill J, Wood MW, Easton A, Nelson M, Underwood-Fowler C, Titball RW, Bancroft GJ, Galyov EE, Microbiology 2004 150 Pt 8 2669 2676 15289563 (Pubitemid 39173270)
6. Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model. Warawa J, Woods DE, FEMS Microbiol Lett 2005 242 1 101 108 10.1016/j.femsle.2004.10.045 15621426 (Pubitemid 40038426)
7. Identification of tomato plant as a novel host model for Burkholderia pseudomallei. Lee YH, Chen Y, Ouyang X, Gan YH, BMC Microbiol 2010 10 28 10.1186/1471-2180-10-28 20109238
8. Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages. Burtnick MN, Brett PJ, Nair V, Warawa JM, Woods DE, Gherardini FC, Infect Immun 2008 76 7 2991 3000 10.1128/IAI.00263-08 18443088
9. An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen. Stevens MP, Wood MW, Taylor LA, Monaghan P, Hawes P, Jones PW, Wallis TS, Galyov EE, Mol Microbiol 2002 46 3 649 659 10.1046/j.1365-2958.2002.03190.x 12410823 (Pubitemid 35365601)
10. Caspase-1 dependent macrophage death induced by Burkholderia pseudomallei. Sun GW, Lu J, Pervaiz S, Cao WP, Gan YH, Cell Microbiol 2005 7 10 1447 1458 10.1111/j.1462-5822.2005.00569.x 16153244 (Pubitemid 41335248)
11. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Miao EA, Mao DP, Yudkovsky N, Bonneau R, Lorang CG, Warren SE, Leaf IA, Aderem A, Proc Natl Acad Sci U S A 2010 107 7 3076 3080 10.1073/pnas.0913087107 20133635
12. Impact of host membrane pore formation by the Yersinia pseudotuberculosis type III secretion system on the macrophage innate immune response. Kwuan L, Adams W, Auerbuch V, Infect Immun 2013 81 3 905 914 10.1128/IAI.01014-12 23297383
13. Innate immune recognition of Yersinia pseudotuberculosis type III secretion. Auerbuch V, Golenbock DT, Isberg RR, PLoS Pathog 2009 5 12 1000686 10.1371/journal.ppat.1000686 19997504
14. The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. Hapfelmeier S, Stecher B, Barthel M, Kremer M, Muller AJ, Heikenwalder M, Stallmach T, Hensel M, Pfeffer K, Akira S, Hardt WD, J Immunol 2005 174 3 1675 1685 10.4049/jimmunol.174.3.1675 15661931
15. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jehanno M, Viala J, Tedin K, Taha MK, Labigne A, Zähringer U, Coyle AJ, DiStefano PS, Bertin J, Sansonetti PJ, Philpott DJ, Science 2003 300 5625 1584 1587 10.1126/science.1084677 12791997 (Pubitemid 36682892)
16. Differential modulation of Nods signaling pathways by fatty acids in human colonic epithelial HCT116 cells. Zhao L, Kwon MJ, Huang S, Lee JY, Fukase K, Inohara N, Hwang DH, J Biol Chem 2007 282 16 11618 11628 10.1074/jbc. M608644200 17303577 (Pubitemid 47100703)
17. Interleukin-8 induction by Burkholderia pseudomallei can occur without Toll-like receptor signaling but requires a functional type III secretion system. Hii CS, Sun GW, Goh JW, Lu J, Stevens MP, Gan YH, J Infect Dis 2008 197 11 1537 1547 10.1086/587905 18419546 (Pubitemid 351706484)
18. Regulation of type VI secretion system during Burkholderia pseudomallei infection. Chen Y, Wong J, Sun GW, Liu Y, Tan GY, Gan YH, Infect Immun 2011 79 8 3064 3073 10.1128/IAI.05148-11 21670170
19. Unraveling type III secretion systems in the highly versatile Burkholderia pseudomallei. Sun GW, Gan YH, Trends Microbiol 2010 18 12 561 568 10.1016/j.tim.2010.09.002 20951592
20. Suppression of host innate immune response by Burkholderia pseudomallei through the virulence factor TssM. Tan KS, Chen Y, Lim YC, Tan GY, Liu Y, Lim YT, Macary P, Gan YH, J Immunol 2010 184 9 5160 5171 10.4049/jimmunol.0902663 20335533
21. Stimulation of autophagy suppresses the intracellular survival of Burkholderia pseudomallei in mammalian cell lines. Cullinane M, Gong L, Li X, Lazar-Adler N, Tra T, Wolvetang E, Prescott M, Boyce JD, Devenish RJ, Adler B, Autophagy 2008 4 6 744 753 18483470
22. BopC is a type III secreted effector protein of Burkholderia pseudomallei. Muangman S, Korbsrisate S, Muangsombut V, Srinon V, Adler NL, Schroeder GN, Frankel G, Galyov EE, FEMS Microbiol Lett 2011 323 1 75 82 10.1111/j.1574-6968.2011.02359.x 22092682
23. A Burkholderia pseudomallei type III secreted protein, BopE, facilitates bacterial invasion of epithelial cells and exhibits guanine nucleotide exchange factor activity. Stevens MP, Friebel A, Taylor LA, Wood MW, Brown PJ, Hardt WD, Galyov EE, J Bacteriol 2003 185 16 4992 4996 10.1128/JB.185.16.4992-4996.2003 12897019 (Pubitemid 36962307)
24. Dissection of the Burkholderia intracellular life cycle using a photothermal nanoblade. French CT, Toesca IJ, Wu TH, Teslaa T, Beaty SM, Wong W, Liu M, Schroder I, Chiou PY, Teitell MA, Miller JF, Proc Natl Acad Sci U S A 2011 108 29 12095 12100 10.1073/pnas.1107183108 21730143
25. Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1. Keestra AM, Winter MG, Auburger JJ, Frassle SP, Xavier MN, Winter SE, Kim A, Poon V, Ravesloot MM, Waldenmaier JF, Tsolis RM, Eigenheer RA, Bäumler AJ, Nature 2013 496 7444 233 237 10.1038/nature12025 23542589
26. Photothermal nanoblade for large cargo delivery into mammalian cells. Wu TH, Teslaa T, Kalim S, French CT, Moghadam S, Wall R, Miller JF, Witte ON, Teitell MA, Chiou PY, Anal Chem 2011 83 4 1321 1327 10.1021/ac102532w 21247066
27. Burkholderia thailandensis as a model system for the study of the virulence-associated type III secretion system of Burkholderia pseudomallei. Haraga A, West TE, Brittnacher MJ, Skerrett SJ, Miller SI, Infect Immun 2008 76 11 5402 5411 10.1128/IAI.00626-08 18779342
28. TAK1, more than just innate immunity. Dai L, Aye Thu C, Liu XY, Xi J, Cheung PC, IUBMB Life 2012 64 10 825 834 10.1002/iub.1078 22941947
29. Anti-apoptotic signalling by the Dot/Icm secretion system of L. pneumophila. Abu-Zant A, Jones S, Asare R, Suttles J, Price C, Graham J, Kwaik YA, Cell Microbiol 2007 9 1 246 264 10.1111/j.1462-5822.2006.00785.x 16911566 (Pubitemid 44896849)
30. Temporal resolution of two-tracked NF-kappaB activation by Legionella pneumophila. Bartfeld S, Engels C, Bauer B, Aurass P, Flieger A, Bruggemann H, Meyer TF, Cell Microbiol 2009 11 11 1638 1651 10.1111/j.1462-5822.2009.01354.x 19573161
31. NF-kappaB translocation prevents host cell death after low-dose challenge by Legionella pneumophila. Losick VP, Isberg RR, J Exp Med 2006 203 9 2177 2189 10.1084/jem.20060766 16940169 (Pubitemid 44352238)
32. Type IV secretion-dependent activation of host MAP kinases induces an increased proinflammatory cytokine response to Legionella pneumophila. Shin S, Case CL, Archer KA, Nogueira CV, Kobayashi KS, Flavell RA, Roy CR, Zamboni DS, PLoS Pathog 2008 4 11 1000220 10.1371/journal.ppat.1000220 19043549
33. LnaB: a Legionella pneumophila activator of NF-kappaB. Losick VP, Haenssler E, Moy MY, Isberg RR, Cell Microbiol 2010 12 8 1083 1097 10.1111/j.1462-5822.2010.01452.x 20148897
34. A Legionella type IV effector activates the NF-kappaB pathway by phosphorylating the IkappaB family of inhibitors. Ge J, Xu H, Li T, Zhou Y, Zhang Z, Li S, Liu L, Shao F, Proc Natl Acad Sci U S A 2009 106 33 13725 13730 10.1073/pnas.0907200106 19666608
35. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. Girardin SE, Tournebize R, Mavris M, Page AL, Li X, Stark GR, Bertin J, DiStefano PS, Yaniv M, Sansonetti PJ, Philpott DJ, EMBO Rep 2001 2 8 736 742 10.1093/embo-reports/kve155 11463746 (Pubitemid 32798718)
36. Salmonella Typhimurium type III secretion effectors stimulate innate immune responses in cultured epithelial cells. Bruno VM, Hannemann S, Lara-Tejero M, Flavell RA, Kleinstein SH, Galan JE, PLoS Pathog 2009 5 8 1000538 10.1371/journal.ppat.1000538 19662166
37. A Salmonella virulence factor activates the NOD1/NOD2 signaling pathway. Keestra AM, Winter MG, Klein-Douwel D, Xavier MN, Winter SE, Kim A, Tsolis RM, Baumler AJ, MBio 2011 2 6 00266-11 22186610
38. Nucleotide-binding oligomerization domain-containing protein 2 regulates suppressor of cytokine signaling 3 expression in Burkholderia pseudomallei-infected mouse macrophage cell line RAW 264.7. Pudla M, Kananurak A, Limposuwan K, Sirisinha S, Utaisincharoen P, Innate Immun 2011 17 6 532 540 10.1177/1753425910385484 21088051
39. The Role of NOD2 in Murine and Human Melioidosis. Myers ND, Chantratita N, Berrington WR, Chierakul W, Limmathurotsakul D, Wuthiekanun V, Robertson JD, Liggitt HD, Peacock SJ, Skerrett SJ, West TE, J Immunol 2014 192 1 300 307 10.4049/jimmunol.1301436 24298015
40. Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Liu B, Koo GC, Yap EH, Chua KL, Gan YH, Infect Immun 2002 70 2 504 511 10.1128/IAI.70.2.504-511.2002 11796576 (Pubitemid 34083807)
41. Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Brett PJ, DeShazer D, Woods DE, Int J Syst Bacteriol 1998 48 Pt 1 317 320 9542103 (Pubitemid 28144666)
42. Small mobilizable multi-purpose cloning vectors derived from the Escherichia coli plasmids pK18 and pK19: selection of defined deletions in the chromosome of Corynebacterium glutamicum. Schafer A, Tauch A, Jager W, Kalinowski J, Thierbach G, Puhler A, Gene 1994 145 1 69 73 10.1016/0378-1119(94) 90324-7 8045426 (Pubitemid 24224965)
43. Genetic tools for select-agent-compliant manipulation of Burkholderia pseudomallei. Choi KH, Mima T, Casart Y, Rholl D, Kumar A, Beacham IR, Schweizer HP, Appl Environ Microbiol 2008 74 4 1064 1075 10.1128/AEM.02430-07 18156318 (Pubitemid 351287077)
44. Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway. Koka V, Huang XR, Chung AC, Wang W, Truong LD, Lan HY, Am J Pathol 2008 172 5 1174 1183 10.2353/ajpath.2008.070762 18403595 (Pubitemid 351671532)